{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:03:24Z","timestamp":1781496204215,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CIBERehd","award":["PI13\/1025"],"award-info":[{"award-number":["PI13\/1025"]}]},{"name":"CIBERehd","award":["PI12\/1984"],"award-info":[{"award-number":["PI12\/1984"]}]},{"name":"CIBERehd","award":["PI13\/0073"],"award-info":[{"award-number":["PI13\/0073"]}]},{"name":"CIBERehd","award":["PI15\/1424"],"award-info":[{"award-number":["PI15\/1424"]}]},{"name":"European Regional Development","award":["CB06\/04\/0071"],"award-info":[{"award-number":["CB06\/04\/0071"]}]},{"name":"European Regional Development","award":["PROMETEOII2014\/035"],"award-info":[{"award-number":["PROMETEOII2014\/035"]}]},{"name":"European Regional Development","award":["UGP-14-93"],"award-info":[{"award-number":["UGP-14-93"]}]},{"name":"European Regional Development","award":["UGP-14-95"],"award-info":[{"award-number":["UGP-14-95"]}]},{"name":"Ministry of Health of the Valencian Regional Government and Carlos III Health Institute","award":["CES10\/030"],"award-info":[{"award-number":["CES10\/030"]}]},{"name":"Ministry of Health of the Valencian Regional Government and Carlos III Health Institute","award":["CP10\/0360"],"award-info":[{"award-number":["CP10\/0360"]}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"crossref","award":["FI11\/00637"],"award-info":[{"award-number":["FI11\/00637"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"crossref","award":["CD14\/00043"],"award-info":[{"award-number":["CD14\/00043"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.atherosclerosis.2016.01.044","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T18:15:18Z","timestamp":1454609718000},"page":"40-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Effects of simvastatin, ezetimibe and simvastatin\/ezetimibe on mitochondrial function and leukocyte\/endothelial cell interactions in patients with hypercholesterolemia"],"prefix":"10.1016","volume":"247","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4099-1905","authenticated-orcid":false,"given":"Antonio","family":"Hernandez-Mijares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Ba\u00f1uls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Rovira-Llopis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Diaz-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Escribano-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"de Pablo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Veses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor M.","family":"Victor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tem.2014.06.008","article-title":"Mitochondrial DNA damage and atherosclerosis","volume":"25","author":"Yu","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2004-0628","article-title":"The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome","volume":"90","author":"Orio","year":"2005","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1567-5688(02)00045-4","article-title":"Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase","volume":"3","author":"Tselepis","year":"2002","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/med.21285","article-title":"Perspectives and potential applications of mitochondria-targeted antioxidants in cardiometabolic diseases and type 2 diabetes","volume":"34","author":"Rocha","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/HYPERTENSIONAHA.113.02627","article-title":"Synergistic effects of high blood cholesterol and hypertension on leukocyte and platelet recruitment in the cerebral microcirculation","volume":"63","author":"Rodrigues","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib6","doi-asserted-by":"crossref","first-page":"H1745","DOI":"10.1152\/ajpheart.00201.2014","article-title":"Platelets, acting in part via P-selectin, mediate cytomegalovirus-induced microvascular dysfunction","volume":"307","author":"Khoretonenko","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0163-7258(03)00055-X","article-title":"The lipid and non-lipid effects of statins","volume":"99","author":"Wierzbicki","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0195-668X(02)00419-0","article-title":"Statin effects beyond lipid lowering are they clinically relevant?","volume":"24","author":"Bonetti","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3132\/dvdr.2008.046","article-title":"Residual Risk Reduction Initiative (R3I). The residual risk reduction initiative: a call of action to reduce residual vascular risk in dyslipidaemic patient","volume":"5","author":"Fruchart","year":"2008","journal-title":"Diab Vasc. Dis. Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib10","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0735-1097(02)02610-4","article-title":"Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia","volume":"40","author":"Davidson","year":"2002","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib11","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1368-5031.2004.00289.x","article-title":"Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia","volume":"58","author":"Davidson","year":"2004","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1517\/14656566.2015.1041504","article-title":"Ezetimibe plus simvastatin for the treatment of hypercholesterolemia","volume":"16","author":"Gryn","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2013.08.013","article-title":"Comparison of the effect of simvastatin versus simvastatin\/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia","volume":"231","author":"Moutzouri","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib14","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/eurheartj\/ehu107","article-title":"The ACC\/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC\/EAS guidelines for the management of dyslipidaemias 2011","volume":"35","author":"Ray","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib15","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2337\/dc12-1224","article-title":"Human leukocyte\/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia","volume":"36","author":"Hernandez-Mijares","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib16","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1089\/ars.2014.6030","article-title":"Is glycemic control modulating endoplasmic reticulum stress in leukocytes of type 2 diabetic patients?","volume":"21","author":"Rovira-Llopis","year":"2014","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib17","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/eurheartj\/ehq181","article-title":"Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial","volume":"31","author":"Berneis","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1185\/03007995.2010.546394","article-title":"The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia","volume":"27","author":"Florentin","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib19","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0735-1097(02)02610-4","article-title":"Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia","volume":"40","author":"Davidson","year":"2002","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib20","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2012.02.016","article-title":"Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials","volume":"223","author":"Morrone","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib22","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.CIR.0000133444.17867.56","article-title":"Established and emerging plasma biomarkers in the prediction of first atherothrombotic events","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib24","doi-asserted-by":"crossref","first-page":"7A","DOI":"10.1016\/S0002-9149(02)03144-2","article-title":"Role of oxidative stress in atherosclerosis","volume":"91","author":"Harrison","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2796.1995.tb01218.x","article-title":"Mitochondrial medicine","volume":"238","author":"Luft","year":"1995","journal-title":"J.\u00a0Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.91.4.955","article-title":"Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects","volume":"91","author":"Anan","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib28","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","article-title":"Mitochondrial diseases in man and mouse","volume":"283","author":"Wallace","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1074248408318628","article-title":"An overview of the extra-lipid effects of rosuvastatin","volume":"13","author":"Kostapanos","year":"2008","journal-title":"J.\u00a0Cardiovasc Pharmacol. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/clc.4960261507","article-title":"Pharmacologic characteristics of statins","volume":"26","author":"McKenney","year":"2003","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/FJC.0b013e31821e8cb2","article-title":"Ezetimibe combined with simvastatin compared with simvastatin alone results in a greater suppression of oxidative stress and enhanced fibrinolysis in patients after acute coronary events","volume":"58","author":"Undas","year":"2011","journal-title":"J.\u00a0Cardiovasc Pharmacol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2016.01.044_bib32","doi-asserted-by":"crossref","first-page":"e72858","DOI":"10.1371\/journal.pone.0072858","article-title":"Effects of lipid-lowering drugs on irisin in human subjects in\u00a0vivo and in human skeletal muscle cells ex\u00a0vivo","volume":"8","author":"Gouni-Berthold","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib33","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1210\/jc.2011-0651","article-title":"Induction of oxidative stress and human leukocyte\/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance","volume":"96","author":"Victor","year":"2011","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib34","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1016\/S0895-7061(01)02069-6","article-title":"Adhesion molecules and their role in vascular disease","volume":"14","author":"Krieglstein","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/CIRCRESAHA.107.151860b","article-title":"Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall","volume":"101","author":"Rao","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib36","doi-asserted-by":"crossref","first-page":"e38912","DOI":"10.1371\/journal.pone.0038912","article-title":"Local oxidative and nitrosative stress increases in the microcirculation during leukocytes-endothelial cell interactions","volume":"7","author":"Kar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib37","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1210\/jc.2011-0651","article-title":"Induction of oxidative stress and human leukocyte\/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance","volume":"96","author":"Victor","year":"2011","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib38","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0002-9440(10)63728-5","article-title":"Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes","volume":"164","author":"Miyahara","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/01.ATV.0000059384.34874.F0","article-title":"Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients","volume":"23","author":"Rezaie-Majd","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.044_bib40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/1755-5922.12126","article-title":"Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients","volume":"33","author":"Cerda","year":"2015","journal-title":"Cardiovasc Ther."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016300430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016300430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T12:25:15Z","timestamp":1589631915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016300430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":40,"alternative-id":["S0021915016300430"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.044","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of simvastatin, ezetimibe and simvastatin\/ezetimibe on mitochondrial function and leukocyte\/endothelial cell interactions in patients with hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}